Search
Feed aggregator
GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
In the largest study of its kind, GSK’s two-drug regimen Dovato demonstrated non-inferior efficacy compared to Gilead Sciences’ three-drug regimen Biktarvy for the treatment of HIV-1.
2024 Job Search Toolkit
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.
World Pharma News
- Model reveals strategies to modify the tumor microenvironment and improve cancer therapy
- Blocking immune cells' path into brain limits neurodegeneration
- Frequent cannabis use tied to more severe epilepsy
- A new technique could accelerate the development of RNA therapies
- The concentration of pharmaceuticals in the blood in under 10 minutes